Moving Forward. Looking Ahead.
The Methodist Hospital Department of Ophthalmology is looking ahead to the future, investing time and resources in both research and technology. In conjunction with The Methodist Hospital Research Institute (TMHRI), we are spearheading several studies in the fields of age-related macular degeneration (AMD) and retinoblastoma. Other research efforts focus on:
- ocular oncology
- diabetic retinopathy
- thyroid ophthalmopathy
- ocular infectious and inflammatory diseases
- ocular stem cell and gene therapies
- neuroprotection in neuro-ophthalmology and glaucoma
At The Methodist Hospital, we know that to be truly leading medicine, we must stay abreast of new technology. By providing the best, most up-to-date equipment and services, we are better able to help the patients who seek treatment for some of the most challenging and complex cases. This is why Methodist offers state-of-the-art neuroimaging technology in the form of a 3T magnet and 64-slice CT scanner, as well as treatment options such as stereotactic conformal radiotherapy, image-guided therapies, TomoTherapy, and linear accelerator technology.
By stewarding technological breakthroughs and using the technology we already have at hand to the best advantage, we are confident that we can realize our goal: taking care of the eyes of tomorrow through our hard work today.
To request an appointment or find a physician, please call our Physician Referral & Health Information Line at
